Application Sponsors
ANDA 211170 | WES PHARMA INC | |
Marketing Status
Application Products
001 | SYRUP;ORAL | 2MG/5ML;10MG/5ML;30MG/5ML | 0 | BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-06-16 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
WES PHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 211170
[companyName] => WES PHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"BROMPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE","activeIngredients":"BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE","strength":"2MG\/5ML;10MG\/5ML;30MG\/5ML","dosageForm":"SYRUP;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"06\/16\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-06-16
)
)